Shares of health-care companies rose as biotechnology stocks continued their recent rebound. The iShares Nasdaq Biotechnology Index exchange-traded fund rose 0.7%, paring losses after falling more than 10% from its September peak. Eli Lilly, one of the biggest makers of insulin, is exploring production of the high-tech devices that deliver the hormone to diabetes patients, The Wall Street Journal reported.
Continue Reading Below
-Rob Curran, firstname.lastname@example.org
(END) Dow Jones Newswires
November 21, 2017 16:27 ET (21:27 GMT)